Our commitment to innovation is unparalleled. Partnering with DSM ensures access to a global network of application labs and expert knowledge, for all your new product development needs.
We have a strong track record of joint innovation and collaboration with key opinion leaders, providing crucial API support across specific applications. We can tailor our approach to match your requirements, developing high-quality, sustainable products that take you further in the pharmaceutical industry.
Contact us to explore how our unique technical capabilities can help you get to market faster.
Global regulatory bodies have introduced a legal obligation for drug manufacturers to implement mitigation strategies that aim to minimize the risk of nitrosamine formation in drug products. The addition of antioxidants to drug formulations is a safe and viable, FDA-recommended mitigation strategy for inhibition of nitrosamine formation in drug products. Prevention of formation of potentially carcinogenic impurities is possible with commonly used ascorbic acid and alpha-tocopherol.
25 May 2022 4 min
10 May 2022 4 min
10 May 2022 5 min
04 Feb 2022 5 min
07 Dec 2021 4 min
06 Dec 2021 4 min
07 Jun 2021 4 min
21 Jan 2021 4 min